# Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment

> **NCT07102030** · — · RECRUITING · sponsor: **Region Stockholm** · enrollment: 900 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07102030
- **Lead sponsor:** Region Stockholm
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2015-02-15
- **Primary completion:** 2029-12-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07102030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07102030, "Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07102030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*